|
Market Cap (2-Jul) $617,674,048 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 21 October 2022, 9:27. The announcement is marked as price sensitive, and is 3 page(s) in length and 235.84kb in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.157% short sold according to ASIC data. It was ranked the 456th most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| BOT Announces Promotion and Focus on NDA Approval Readiness | 21 October 2022, 9:27 |
| Letter to Shareholders - Annual General Meeting | 21 October 2022, 9:23 |
| Notice of Annual General Meeting/Proxy Form | 21 October 2022, 9:21 |
| Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea | 13 October 2022, 9:47 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 